Cargando…
Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice
Primary sclerosing cholangitis (PSC) is a cholestatic liver disease of unknown etiopathogenesis characterized by fibrous cholangiopathy of large and small bile ducts. Systemic administration of a murine TNF-related apoptosis-inducing ligand (TRAIL) receptor agonist induces a sclerosing cholangitis i...
Autores principales: | Guicciardi, Maria Eugenia, Krishnan, Anuradha, Bronk, Steven F, Hirsova, Petra, Griffith, Thomas S, Gores, Gregory J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386369/ https://www.ncbi.nlm.nih.gov/pubmed/28055006 http://dx.doi.org/10.1038/cddis.2016.459 |
Ejemplares similares
-
TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity
por: Hirsova, Petra, et al.
Publicado: (2017) -
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2013) -
IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids
por: Garcia Moreno, Ana Sofia, et al.
Publicado: (2023) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010)